Skip to content
healthcare.dev

Akovaz

NDC 51754-4250, ephedrine sulfate, injection, from Exela Pharma Sciences, LLC.

Product NDC
51754-4250
Status
Listed
Labeler
Exela Pharma Sciences, LLC
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA208289
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51754-4250 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • EPHEDRINE SULFATE5 mg/mL

Pharmacologic classes

Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Increased Norepinephrine Activity [PE]; Norepinephrine Releasing Agent [EPC]; alpha-Adrenergic Agonist [EPC]; beta-Adrenergic Agonist [EPC]

Package NDCNDC-11Package
51754-4250-35175442500310 SYRINGE, PLASTIC in 1 CARTON (51754-4250-3) / 5 mL in 1 SYRINGE, PLASTIC

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e92f3eda-33eb-4b34-9e8b-db8d32a5dbd9

Use it

Look up 51754-4250 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51754-4250 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51754-4250. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.